Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI) "STRAWINSKI"
Recruiting
Phase N/A Results N/ASummary of Purpose
Development of stroke associated pneumonia (SAP) has a detrimental effect on stroke outcome. Biomarker-guided antibiotic treatment of patients at high risk for pneumonia may help to improve stroke outcome. Therefore, the investigators will evaluate whether intensified infection monitoring via Procalcitonin guiding an early standardized antibiotic treatment improves functional outcome after stroke compared with...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 2 February 2012.
| 1 Dec 2010 | 21 Dec 2010 | 1 Jul 2012 | 1 Dec 2012 | 1 Feb 2012 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Double Blind (Subject, Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Andreas Meisel, MD
- Lena Ulm, MD
lena.ulm@charite.de +49 30 450
View Trial Locations
Recruitment
- Enrollment: 200
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigators
- Andreas Meisel, MD
Charite University Berlin (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center NCRC)
- Stefan Anker, MD PhD
Charité University Berlin (Dept of Cardiology)
